Department of Psychiatry and Psychology Mayo Clinic, Rochester, MN, United States of America.
Universidad Autónoma de Nuevo León, School of Medicine and University Hospital "Dr. José Eleuterio González", Psychiatry Department, Monterrey, Mexico.
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110187. doi: 10.1016/j.pnpbp.2020.110187. Epub 2020 Dec 1.
In recent decades, the diagnostic and therapeutic implications of the microbiome changes and the impact of probiotic supplementation have increased rapidly. However, the potential for clinical translation of microbiome research for children and adolescents with psychiatric disorders is unclear. This review examined available evidence related to gut microbiota as well as the impact of probiotic supplementation on psychiatric disorders in the pediatric population reported to date.
We performed a literature search for the gut microbiota in child and adolescent population (0-18 years old) with mental health disorders from July 1999 through July 2019 in several databases: ClinicalTrials.gov, Ovid EBM Reviews, Ovid Embase, Ovid Medline, Ovid PsycINFO, Scopus, and Web of Science.
A total of 7 studies met inclusion criteria consisting of randomized controlled trials and cohort studies that examined various associations between psychiatric disorders and gut microbiota in youth. Six studies examined the effects of various treatment interventions such as probiotic supplementation on microbiota composition and behaviors. One study showed an increase in prosocial behavior in children with Autism Spectrum Disorder (ASD) and an increase in the Lachnospiraceae family following prebiotic supplementation. Another study suggested that prebiotic supplementation increased bifidobacterial populations for ASD and healthy controls. A study evaluating infant supplementation of prebiotics showed both a decreased likelihood of developing Attention Deficit Hyperactivity Disorder (ADHD) or ASD and decreased gut Bifidobacterium. One study did not find significant differences in microbiome composition after micronutrient treatment.
The main goal of this systematic review was to comprehensively examine and summarize the current evidence focused on the potential effect of the relationship between microbiota gut composition as well as the effects of probiotic supplementation on psychiatric disorders in children and adolescents. This is a relatively new area of research and the number of included studies is limited. More studies are needed to determine whether gut dysbiosis leads to the development and/or contributes to the severity of mental disorders or whether gut dysbiosis is a result of other processes that accompany mental disorders.
A better understanding of the specific bacteria contributions, gut-brain pathways, and role in pathophysiological mechanisms in neuropsychiatric disorders in the child and adolescent populations can possibly provide alternative tools for a clinical psychiatrist. Moreover, it may ultimately aid the clinician with intervention strategies, or detect populations at risk for developing neuropsychiatric disorders.
近几十年来,微生物组变化的诊断和治疗意义以及益生菌补充的影响迅速增加。然而,对于儿科精神疾病患者的微生物组研究的临床转化潜力尚不清楚。本综述检查了迄今为止报道的儿童和青少年人群中肠道微生物组以及益生菌补充对精神疾病的影响的相关证据。
我们在几个数据库中对儿童和青少年人群(0-18 岁)的肠道微生物组进行了文献检索:临床试验.gov、ovid EBM Reviews、ovid Embase、ovid Medline、ovid PsycINFO、Scopus 和 Web of Science。
共有 7 项研究符合纳入标准,包括随机对照试验和队列研究,这些研究检查了青少年精神疾病与肠道微生物组之间的各种关联。六项研究检查了各种治疗干预措施(如益生菌补充)对微生物组组成和行为的影响。一项研究表明,自闭症谱系障碍(ASD)儿童的亲社会行为增加,以及在补充益生元后 Lachnospiraceae 家族增加。另一项研究表明,补充益生元可增加 ASD 和健康对照组的双歧杆菌种群。一项评估婴儿补充益生元的研究表明,补充益生元可降低儿童患注意力缺陷多动障碍(ADHD)或 ASD 的可能性,并减少肠道双歧杆菌。一项研究发现,在接受微量营养素治疗后,微生物组组成没有显著差异。
本系统综述的主要目的是全面检查和总结目前的证据,重点关注肠道微生物群组成的潜在影响,以及益生菌补充对儿童和青少年精神疾病的影响。这是一个相对较新的研究领域,纳入的研究数量有限。需要更多的研究来确定肠道菌群失调是否导致精神障碍的发展和/或导致精神障碍的严重程度,或者肠道菌群失调是否是伴随精神障碍的其他过程的结果。
更好地了解儿童和青少年人群中神经精神疾病的特定细菌贡献、肠道-大脑途径以及在病理生理机制中的作用,可能为临床精神科医生提供替代工具。此外,它最终可能有助于临床医生进行干预策略,或检测可能发展为神经精神疾病的人群。